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Using a combination of fluorescence measurements of intracellular Ca2+ ion concentration ([Ca2+]i) and membrane potential we have
investigated the sensitivity to serine/threonine phosphatase inhibition of Ca2+ entry stimulated by activation of the Ca2+ release-activated Ca2+
(CRAC) entry pathway in rat basophilic leukemia cells. In both suspension and adherent cells, addition of the type1/2A phosphatase inhibitor
calyculin A, during activation of CRAC uptake, resulted in a fall in [Ca2+]i to near preactivation levels. Pre-treatment with calyculin A abolished
the component of the Ca2+ rise associated with activation of CRAC uptake and inhibited Mn2+ entry, consistent with a requirement of phosphatase
activity for activation of the pathway. Depletion of intracellular Ca2+ stores is accompanied by a large depolarisation which is absolutely
dependent upon Ca2+ entry via the CRAC uptake pathway. Application of calyculin A or okadaic acid, a structurally unrelated phosphatase
antagonist inhibits this depolarisation. Taken in concert, these data demonstrate a marked sensitivity of the CRAC entry pathway to inhibition by
calyculin A and okadaic acid.
D 2005 Elsevier B.V. All rights reserved.Keywords: Phosphatase; CRAC; RBL cell; Calyculin A; Okadaic acid; Calcium1. Introduction
Release of Ca2+ from intracellular storage compartments is a
ubiquitous signal for the activation of a Ca2+ entry pathway in
the plasma membrane of non-excitable cells, a process termed
store-regulated Ca2+ uptake (SRCU) or capacitative Ca2+ entry
[1]. To date, both the molecular origin of the entry pathway and
the signal linking depleted stores to its activation remain
controversial. Much effort has focused upon the role of the
superfamily of transient receptor potential channels as the
molecular correlate of the pathway while numerous mechan-
isms have been postulated to explain the signal linking store
depletion to pathway activation. Mechanisms including gener-
ation of a diffusable message released during store depletion
and configurational or secretion-like coupling, a process0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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1 These authors contributed equally.whereby Ca2+ stores reversibly couple to the plasma membrane
during store depletion have been proposed (reviewed in [2]).
In spite of the uncertainty surrounding the mechanism of
communication between intracellular stores and the plasma
membrane, a large body of evidence has accumulated
implicating a serine/threonine phosphorylation event in the
regulation of the pathway. Activation of protein kinase C
(PKC) by phorbol ester has been shown to inhibit SRCU in a
large number of cells including the T-cell line Jurkat [3],
human neutrophils [4], peripheral T-lymphocytes [5], Dro-
sophila photoreceptors [6], HL60 cells [7] and rat basophilic
leukemia (RBL) cells [8], while modest activation of PKC has
been reported to enhance SRCU in oocytes [9] and a pancreatic
cell line [10]. In contrast, we have found no effect of PKC
stimulation on SRCU in rat thymic lymphocytes [11], a finding
supported by work in RBL cells [12].
Modulation of SRCU by serine/threonine phosphorylation is
further supported by experimental evidence derived from
inhibition of serine/threonine phosphatase activity. Inhibition
of type 1/2A phosphatase activity by addition of okadaic acidta 1718 (2005) 32 – 43
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mediated SRCU in HeLa cells [13], thyroid FRTL-5 cells [14],
human neutrophils [4], salivary epithelial cells [15], rat thymic
lymphocytes [11], DD1T-2 transformed smooth muscle cells
[16], A7r5 smooth muscle cells [16] and human platelets [17].
The CRAC entry pathway is the prototypical and best
electrophysiologically characterised SRCU pathway present in
the RBL and Jurkat cell lines [18,19]. Electrophysiological
isolation of the current correlate of CRAC uptake has revealed
a highly Ca2+ selective pathway with a well-defined perme-
ability sequence, marked inward rectification and Ca2+-
dependent fast and slow inactivation to name but five
hallmarks of this pathway (reviewed in [2]). Electrophysiolog-
ical isolation of SRCU in other cell types invites immediate
comparison with the CRAC uptake pathway’s well-described
electrophysiological finger print. Interestingly, while calyculin
A-mediated inhibition of SRCU has been reported in numerous
cell types, the CRAC pathway has been reported by Bakowski
and collaborators to be insensitive to modulation by this
reagent [20]. It would appear that the CRAC entry pathway in
RBL cells is distinct from SRCU in other cell types in its
apparent lack of sensitivity to phosphatase inhibition. Thus,
modulation of phosphatase activity cannot be a ubiquitous
signal underlying the activation and/or regulation of the SRCU
family.
In an attempt to reconcile this apparent discrepancy, we
have undertaken experiments to re-evaluate the role of
calyculin A and okadaic acid, established inhibitors of
type1/2A serine/threonine phosphatase activity [21] in the
modulation of the CRAC entry pathway in intact RBL cells. In
these experiments, we have monitored both changes in [Ca2+]i
and membrane potential. In contrast to previous findings [20],
we report an absolute requirement for calyculin A- and
okadaic acid-sensitive phosphatase activity for the activation
and maintenance of Ca2+ entry via the CRAC uptake pathway
in intact RBL cells. Based upon these data, the role of
modulation of the CRAC pathway by phosphatase activity
must be re-evaluated. Regulation of phosphatase activity may
be a crucial signal controlling activation and/or modulation of
the entire class of SRCU pathways including the CRAC
pathway.2. Materials and methods
2.1. Cell culture
RBL-1 cells were kindly provided by Dr. Steve Ikeda, (NIH, Bethesda MD.,
USA). RBL-1 cells were propagated in Minimum Essential Medium plus Earles
salts (Gibco, Paisley, UK), supplemented with 1% non-essential amino acids
(Sigma, Gillingham, UK or Gibco, Paisley, UK), 2 mM l-glutamine (Sigma,
Gillingham, UK or Gibco, Paisley, UK), 100 U/ml penicillin, 100 Ag/ml
streptomycin, 2.5 Ag/ml amphotericin (Sigma, Gillingham, Dorset, UK) and
10% fetal calf serum (FCS) (Gibco, Paisley, UK). In some experiments,
amphotericin was omitted. The presence or absence of amphotericin had no
detectable impact upon the outcome of the experiments. Cultures were
incubated in a humidified 95/5% air/CO2 atmosphere at 37 -C. Cultures were
propagated by passaging nonadherent cells taken from dense cultures as
previously reported [22,23] or by firmly tapping the flask on the side of the lab
bench to release lightly adherent cells.In some experiments, cells were allowed to adhere to sterile glass cover
slips for 24 to 48 h prior to their use.
2.2. Reagents
The acetoxymethyl (AM) ester derivatives of fluo-3 and fura-2 were
purchased from TeFlabs (Austin, TX, USA) and were made up as 1 mM stocks
in dimethylsulfoxide (DMSO) containing 20% pluronic. bis-(1,3-diethylthio-
barbituric acid) trimethine oxonol (bis-oxonol) was purchased from Molecular
Probes (Leiden, ND) and was made up as a 50 AM stock in DMSO. HEPES,
NaCl, KCl, HCl, NaOH, KOH, CaCl2, MgCl2, GdCl3, NiCl2, MnCl2, d-
glucose, N-methyl-d-glucamine (NMG), DMSO, 2-aminoethoxydiphenyl
borate (2-APB) and EGTA were purchased from Sigma-Aldrich (Gillingham,
Dorset, UK). 2-APB was made up in DMSO as a 50 mM stock. Thapsigargin
and ionomycin were purchased from Merck Biosciences (San Diego, CA,
USA) and were made up as concentrated stocks in DMSO and ethyl alcohol
respectively. Calyculin A and the Na+ salt of okadaic acid were purchased from
LC Laboratories (Woburn, MA, USA) and were made up as concentrated
stocks in ethyl alcohol and DMSO respectively. Gramicidin-D was purchased
from Sigma-Aldrich (Gillingham, Dorset, UK) and was made up as a
concentrated stock in ethyl alcohol (Sigma-Aldrich, Gillingham, Dorset, UK).
GdCl3 and NiCl2 were made up as concentrated stocks in distilled H2O.
None of the reagents used adversely interacted with fluo-3 or bis-oxonol
with the exception of GdCl3, NiCl2 and MnCl2 which alter the fluorescence of
fluo-3 and fura-2.
2.3. Solutions
Basic Na+ containing solution had the following composition in mM; 145
NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10 Glucose, 10 HEPES, pH 7.4 with NaOH.
When required, extra Ca2+ was added directly to this solution. Na+-free
solutions were made by equimolar replacement of Na+ with NMG. Ca2+-free
solutions were made by omitting Ca2+ and in some cases adding EGTA at the
indicated concentration. Solutions were stored long term at 20 -C and
refrigerated short term.
2.4. Measurements of [Ca2+]i in cell suspensions
[Ca2+]i was measured fluorimetrically in cell suspensions using fluo-3.
Culture flasks were gently tapped to release lightly adherent cells, the culture
medium centrifuged and the cells resuspended in basic Na+ solution. After
determination of the cell density, cells were loaded with fluo-3 by incubation
with the AM ester derivative of fluo-3. 25106 cells/ml were loaded with 3
AM fluo-3-AM for 25 min at 37 -C. Cells were then centrifuged, resuspended
in basic Na+ solution and stored in the dark at room temperature until required.
For intracellular Ca2+ measurements, cells were centrifuged and added directly
to a cuvette to give a final concentration of between 1 and 2106 cell/ml and
fluo-3 fluorescence monitored under continual stirring in a cuvette-based
fluorescence spectrophotometer (Cairn Research Ltd., Faversham, Kent, UK)
(Ex 488 nm, 10 nm half bandwidth, Em 530 nm longpass, Comar Instruments,
Cambridge, Cambridgeshire, UK). The photomultiplier tube output was
externally filtered a 15 Hz using a lowpass Bessel filter (Frequency Devices
Inc., Haverhill, MA, USA) and sampled at 30 Hz using a Digidata 1322A
analogue to digital acquisition system (Axon Instruments, Union City, CA,
USA) controlled by a Macintosh computer running Axograph Software (Axon
Instruments, Union City, CA, USA). To calibrate the fluo-3 signal the
maximum fluorescence in the presence of saturating Ca2+ ( Fmax) and the
minimum fluorescence in the complete absence of Ca2+ ( Fmin) is required. At
the end of each experiment maximum fluorescence was determined by the
addition of ionomycin in the presence of 1 mM Ca2+. This was followed by the
addition of 3 to 5 mM Mn2+ and quenching of the fluo-3 signal ( FMn).
Experiments using free fluo-3 in solution revealed a consistent relationship
between Fmax, Fmin and FMn. Fluorescence of fluo-3 in the presence of Mn
2+
( FMn) was consistently greater than the fluorescence in the complete absence of
Ca2+ ( Fmin). The decline in fluorescence from Fmax observed by addition of
Mn2+ is consistently 89% of the decline observed by complete removal of Ca2+
( Fmin). This relationship was used to calculate the minimum fluorescence value
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calculated according to the following relationship:
Ca2þ
 
i
¼ 390 F  Fminð Þ= Fmax  Fð Þ
where Fmin is the calculated minimum fluorescence in the absence of Ca
2+,
Fmax is the maximum fluorescence in the presence of ionomycin and
extracellular Ca2+, and 390 is the dissociation constant for fluo-3 in nM as
taken from the Molecular Probes web page (http://probes.invitrogen.com/
handbook/). Prior to applying the calibration, the data were corrected for fluo-3
leakage out of the cell. Leakage of fluo-3 out of the cell was evident as a slow
linear increase in the fluorescence signal over the course of the experiment as
fluo-3 leaked into the high Ca2+ environment of the external saline. The
equation defining leakage was determined by fitting a linear regression to the
initial baseline portion of the data. The regression was used to subtract the
leakage component from each corresponding point in the data series.
All experiments were performed at room temperature.
2.5. Measurements of fluo-3 fluorescence in adherent cells
Fluo-3 fluorescence was recorded from adherent cells on a Zeiss Axiovert
100M inverted microscope equipped with a Zeiss LSM 510 confocal laser
scanning module employing photo multiplier tubes for emission detection (Carl
Zeiss Ltd., Welwyn Garden City, UK). Experiments were performed with the
pinhole fully open thus ensuring the capture of fluorescence from the entire z
plane of the cells. Small sections of coverslip were inserted into the
experimental chamber and superfused with basic Na+ containing solution to
remove residual culture medium. For fluo-3 loading, half of the chamber
volume was removed and replaced with an equivalent volume of solution
containing fluo-3-AM (3 AM final loading concentration). Loading was
confirmed after 10 to 15 min by capturing wide field images using the 488-
nm excitation line of an argon ion laser and a long pass 505 emission filter.
Images were captured at a resolution of 128128 pixels using a Zeiss 40 oil
immersion objective (NA 1.3). Image fields contained from 6 to 35 adherent
cells. Following confirmation of adequate fluo-3 loading the chamber was
superfused with fluo-3-free basic Na+ containing solution, image acquisition
initiated and images captured every 3 s. Solution changes were made by gravity
controlled superfusion with the exception of the application of calyculin A. For
calyculin A application half the chamber volume was removed and mixed with
calyculin A before careful reintroduction into the chamber (final concentration
200 nM).
Confocal control and image acquisition were achieved using proprietary
software provided with the confocal module. Image fluorescence was analysed
using LSM Toolbox (Dr. Christof Schwiening, Department of Physiology,
University of Cambridge). Images were background subtracted and the average
fluorescence from the entire field of view determined for each image in the
experiment. Image fluorescence is expressed as f/fo ratios to normalise the
average image fluorescence ( f ) to the starting fluorescence immediately before
addition of thapsigargin ( fo). This enables the comparison of image fields
containing different cell numbers and thus average image fluorescence, and
under conditions of different fluo-3 loading, laser intensity and photomultipier
tube sensitivity. We have chosen to use average fluorescence from entire image
fields rather than regions of interest defining single cells as the calyculin A-
dependent disruption of the cytoskeleton resulted in re-organisation of the cell
morphology. This made the definition of individual cells in close proximity
difficult. In control cells, where cytoskeletal disruption does not occur, a
comparison of average image field versus average individual cell fluorescence
yields identical dynamic changes in cell fluorescence thus validating our
analysis.
2.6. Measurements of Mn2+ entry in cell suspensions
Mn2+ entry in cell suspensions was assessed using the quench of
intracellular fura-2 at the Ca2+-insensitive isosbestic wavelength [24]. Culture
flasks were tapped to release lightly adherent cells, the culture medium
centrifuged and the cells resuspended in basic Na+ solution. After determination
of the cell density, cells were loaded with fura-2 by incubation with the AM
ester derivative of fura-2. 16 to 25106 cells/ml were loaded with 5 AM fura-2-AM for 25 min at 37 -C. Cells were then centrifuged, resuspended in basic Na+
solution, aliquoted into individual microcentrifuge tubes and stored in the dark
at room temperature until required. Cells were incubated with 200 nM calyculin
A for 15 min at room temperature. Control cells were incubated with the
appropriate ethanol concentration as a solvent control. After 15 min, the cells
were centrifuged, added directly to a cuvette containing 200 nM calyculin A or
appropriate ethanol volume as a solvent control and fura-2 fluorescence
monitored under continual stirring at the isosbestic wavelength in the cuvette-
based fluorescence spectrophotometer (Cairn Research Ltd., Faversham, Kent,
UK). The isosbestic excitation wavelength was achieved using a Cairn
Optoscan monochromator (Cairn Research Ltd., Faversham, Kent, UK). The
accuracy of the isosbestic wavelength was assessed by monitoring the
fluorescence change associated with application of high concentration of
ionomycin to cells suspended in basic Na+-containing solution containing 1
mM Ca2+ and 0.1 mM EGTA. Wavelengths between 360 and 363 nm (10 nm
bandwidth) were used and emission was collected using a 494 nm longpass
filter (Comar Instruments, Cambridge, Cambridgeshire, UK). The photomul-
tiplier tube output was filtered and acquired as described for intracellular Ca2+
measurements employing fluo-3. For presentation, the data were further
digitally filtered at 0.5 Hz using Axograph software. The control and calyculin
A-treated traces were scaled to give equivalent starting fluorescence immedi-
ately before application of thapsigargin thus controlling for differences in
fluorescence associated with differences in cell number in the cuvette. Both
control and calycuin A-treated cells were taken from the same batch of fura-2-
loaded cells.
All experiments were performed at room temperature.
2.7. Measurements of membrane potential in cell suspensions
Membrane potential was measured fluorimetrically in cell suspensions using
bis-oxonol as previously reported by our laboratory [11,23,25,26]. Cells at a
concentration of 1106 cells/ml were equilibrated in a cuvette with 150 nM bis-
oxonol and fluorescence monitored under continual stirring using the Cairn
spectrophotometer (Ex 532 nm, 10 nm half bandwidth, Em 580 nm, 10 nm half
bandwidth, Comar Instruments, Cambridge, Cambridgeshire, UK). The photo-
multiplier tube output was externally filtered at 15 Hz and sampled at 30 Hz as
described for fluo-3 measurements. In some experiments an external calibration
of the photomultiplier tube output was made by adding gramicidin to cells
suspended in media containing varying ratios of Na+ and NMG+ and
constructing a calibration curve as previously reported [11,23,25,26]. In the
absence of a complete calibration, the 0 mV value was determined by adding
gramicidin at the end of each experiment. Incorporation of a large monovalent
cation conductance by the addition of gramicidin takes the membrane potential
to approximately 0 mV when applied to cells suspended in basic Na+ solution as
previously reported [11,23,25,26].
All experiments were performed at room temperature.
3. Results
3.1. 2-APB sensitivity of the thapsigargin-mediated elevation in
[Ca2+]i in cell suspensions
Changes in [Ca2+]i associated with thapsigargin-mediated
activation of CRAC entry were monitored in cell suspensions
of fluo-3-loaded RBL-1 cells. Fig. 1A shows a representative
response to application of 100 nM thapsigargin recorded at
room temperature in cell suspensions (n =12). The rise in
[Ca2+]i induced by thapsigargin was biphasic, with a rapid rise
in [Ca2+]i followed by a secondary rise which occurred with a
variable time constant. The secondary rise was followed by a
decline in [Ca2+]i to a plateau phase. Application of 2-APB, a
potent inhibitor of ICRAC in RBL cells ([20,27,28] and M.J.
Mason unpublished observations), resulted in a marked decline
in [Ca2+]i to a value approaching pre-thapsigargin exposure.
Fig. 1. Biphasic rise in [Ca2+]i mediated by thapsigargin-induced activation of
the CRAC entry pathway in RBL-1 cell suspensions. (A) Fluo-3-loaded cells
were suspended in basic Na+ solution containing 1 mM Ca2+. Where indicated,
100 nM thapsigargin and 25 AM 2-APB were added. (B) Comparison of the
[Ca2+]i changes mediated by thapsigargin in the presence and absence of
extracellular Ca2+. Fluo-3-loaded cells were suspended in basic Na+ solution in
the presence or absence (200 AM EGTA added) of 1 mM extracellular Ca2+.
Where indicated, 100 nM thapsigargin was added directly to the cuvette.
Fig. 2. Calyculin A sensitivity of the rise in [Ca2+]i mediated by activation of
the CRAC entry pathway in cell suspensions. (A) Control response to depletion
of intracellular Ca2+ stores and the activation of the CRAC entry pathway.
Fluo-3-loaded cells were suspended in basic Na+ solution containing 1 mM
Ca2+. Where indicated, 100 nM thapsigargin and 25 AM 2-APB were added.
(B) Effect of application of 200 nM calyculin A on the thapsigargin-mediated
rise in [Ca2+]i. Fluo-3-loaded cells were suspended in basic Na
+ solution
containing 1 mM Ca2+. 100 nM thapsigargin, 200 nM calyculin A and 25 AM
2-APM were added to the cuvette where indicated.
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[Ca2+]i being a result of CRAC uptake from the extracellular
solution.
The initial biphasic elevation in [Ca2+]i in response to
thapsigargin most likely arises from release of Ca2+ from
intracellular stores followed by influx of Ca2+ from the
extracellular solution. This interpretation is supported by the
observation that release of Ca2+ from intracellular stores in
cells suspended in Ca2+ free solution shows a similar temporal
rise in [Ca2+]i devoid of the secondary Ca
2+ rise seen in the
presence of extracellular Ca2+ (Fig. 1B, n =2).
3.2. Calyculin A sensitivity of the CRAC uptake-mediated rise
in [Ca2+]i
To investigate the role of type 1/2A phosphatase activity in
the regulation of CRAC uptake, we have applied the
phosphatase inhibitor calyculin A (200 nM) at the peak of
the thapsigargin-mediated rise in [Ca2+]i. As shown in Fig. 2B
(n =7), calyculin A application was accompanied, after a brief
interval, by a dramatic fall in [Ca2+]i to pre-thapsigargin levels
and an abolition of the large 2-APB-sensitive component of the
Ca2+ rise observed in control cells (Fig. 2A, n =12).
To address the sensitivity of the CRAC entry pathway
activation process to phosphatase inhibition we have pre-incubated cells at room temperature for 30 min with 200 nM
calyculin A prior to application of thapsigargin. Application of
thapsigargin under these conditions resulted in a single
monophasic rise in [Ca2+]i that was followed by a fall in
Ca2+ to pre-thapsigargin levels (Fig. 3B, n =3). Application of
2-APB had no effect on [Ca2+]i consistent with inhibition of the
2-APB-sensitive component of the Ca2+ rise (i.e., CRAC
entry). Control experiments in which cells were treated with
solvent under identical conditions showed marked activation of
CRAC uptake as evidenced by the secondary rise in [Ca2+]i in
response to Ca2+ store depletion and a large 2-APB component
of the sustained Ca2+ rise (Fig. 3A, n=3). Superimposing the
experimental and control traces clearly shows that calyculin A
pre-exposure inhibits the secondary rise in Ca2+ attributed to
activation of the CRAC entry pathway while leaving the initial
rise (attributable to Ca2+ release from intracellular stores)
unaffected.
Experiments were undertaken to determine the influence of
cell adherence on the calyculin A sensitivity of the rise in
intracellular Ca2+ mediated via the CRAC pathway. Fig. 4A
shows the average fluorescence of a field containing 35
adherent cells during application of 100 nM thapsigargin.
The biphasic rise in fluo-3 fluorescence detected in adherent
Fig. 4. Calyculin A sensitivity of the rise in fluo-3 fluorescence induced by
activation of the CRAC entry pathway in adherent cells. Confocal
measurement of fluo-3 fluorescence in adherent cells. (A) Cells were
superfused with basic Na+ solution containing 1 mM Ca2+ and wide field
images from a field containing 35 adherent cells were collected every 3 s
with the pin hole wide open to ensure capture of the fluorescence from the
entire cell. Where indicated, 100 nM thapsigargin or 0 Ca2+ solution was
superfused into the chamber. Average image fluorescence ( f ) was calculated
for each image in the time series and normalised to the initial image
fluorescence ( fo) immediately prior to thapsigargin application. (B) Cells
were superfused with basic Na+ solution containing 1 mM Ca2+ and wide
field images from a field containing 14 adherent cells were collected every 3
s and analysed as in panel A. Where indicated 100 nM thapsigargin or 0
Ca2+ solution was superfused into the chamber. 200 nM calyculin A was
added directly to the chamber where indicated as detailed in Materials and
methods.
Fig. 3. Pre-incubation with calyculin A inhibits thapsigargin-mediated
activation of the CRAC entry pathway in cell suspensions. (A) Fluo-3-
loaded cells were incubated at room temperature for 30 min with solvent
control (ethanol), spun and resuspended in the cuvette in basic Na+ solution
containing 1 mM Ca2+. Where indicated, 100 nM thapsigargin and 25 AM
2-APB were added. (B) Fluo-3-loaded cells were incubated at room
temperature for 30 min in the presence of 200 nM calyculin A, spun and
resuspended in the cuvette containing basic Na+ solution containing 1 mM
Ca2+ and supplemented with 200 nM calyculin A. Where indicated 100 nM
thapsigargin and 25 AM 2-APB were added to the cuvette. (C) The traces
in panels A and B are superimposed for comparison of the [Ca2+]i response
to depletion of intracellular Ca2+ stores stimulated by addition of
thapsigargin.
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sions (Figs. 1 and 2) and was followed by a decline in cell
fluorescence to a sustained plateau value. This sustained rise in
fluo-3 fluorescence is dependent upon Ca2+ entry from the
extracellular medium since removal of extracellular Ca2+
results in a marked decline in fluo-3 fluorescence. Re-addition
of extracellular Ca2+ is accompanied by a rapid increase in
fluorescence consistent with rapid Ca2+ entry. The thapsigar-
gin-mediated rise in fluo-3 fluorescence presented in Fig. 4A is
representative of the response observed in 7 of 7 control cover
slips. The sensitivity of the thapsigargin-mediated rise in
fluorescence to calyculin A in adherent cells was tested by
applying the phosphatase inhibitor at the peak of the
thapsigargin response. Fig. 4B shows the effect of addition of
200 nM calyculin A on the average fluorescence recorded from
a field containing 14 cells. Addition of calyculin A isaccompanied by a marked decline in fluorescence with kinetics
similar to those recorded in cell suspensions (Fig. 2B). In the
presence of calyculin A, subsequent removal and reintroduc-
tion of extracellular Ca2+ resulted in only small changes in
fluo-3 fluorescence consistent with potent inhibition of the
CRAC entry pathway. The dramatic fall in fluo-3 fluorescence
in the presence of calyculin Awas observed in 3 of 3 coverslips
tested.
On the basis of these data, we conclude that adherent cells
respond to calyculin A in a manner indistinguishable from
suspension cells.
Fig. 5. Calyculin A sensitivity of thapsigargin-mediated Mn2+ entry in cell
suspensions. Fura-2-loaded cells were incubated for 15 min in basic Na+
solution augmented with 200 nM calyculin A or ethanol as a solvent control for
calyculin A. The cells were spun down and added directly to the cuvette
containing 200 nM calyculin A or appropriate ethanol concentrations as control
and fura-2 fluorescence at the isobestic wavelength monitored. 25 AM MnCl2
was added to the cuvette approximately 60 s prior to addition of 100 nM
thapsigargin. 4 AM ionomycin was added to transport Mn2+ into the cell and
fully quench fura-2 fluorescence.
Fig. 6. Membrane depolarisation accompanying activation of the CRAC entry
pathway is reversed by 2-APB addition. Bis-oxonol measurement of membrane
potential in cells suspended in basic Na+ solution containing 5 mM Ca2+. (A)
Following cell equilibration with bis-oxonol, 100 nM thapsigargin was added
to the cuvette where indicated. (B) Following cell equilibration with bis-
oxonol, 100 nM thapsigargin and 25 AM 2-APB were added to the cuvette
where indicated.
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The data above are consistent with calyculin A inhibition of
the CRAC pathway or its activation process. However, these
data may also be explained by upregulation of Ca2+ extrusion
processes secondary to phosphatase inhibition. Mn2+ is poorly
transported on Ca2+ extrusion pathways, therefore, Mn2+ entry
is functionally unidirectional. We have previously reported that
a small but measurable Mn2+ current is carried by the CRAC
pathway in RBL-1 cells [22] while Mn2+ entry has been used to
probe the CRAC entry pathway in RBL-2H3 cells [29].
Experiments were undertaken to define the influence of
calyculin A on thapsigargin-mediated Mn2+ entry. A represen-
tative experiment is shown in Fig. 5. In control cells, addition
of 100 nM thapsigargin results in pronounced augmentation of
the basal Mn2+ entry rate consistent with activation of the
CRAC entry pathway. Subsequent addition of 4 AM ionomycin
results in ionophoretic Mn2+ transport into the cell and
complete quench of fura-2 fluorescence. Pretreatment of cells
with 200 nM calyculin A for 15 consistently resulted in a
dramatic inhibition of the rate of thapsigargin-stimulated Mn2+
entry (n =7). Given the unidirectional nature of Mn2+ entry,
these data are consistent with calyculin A inhibition of the
CRAC entry pathway or its activation mechanism.
3.4. Depolarisation mediated by activation of the CRAC uptake
pathway
Membrane depolarisation has a dramatic inhibitory influ-
ence on the CRAC entry pathway in RBL cells [23,30]. Theinfluence of depolarisation arises both as a result of the loss of
inwardly directed driving force and the inwardly rectifying
nature of the current–voltage relationship for the CRAC entry
pathway [18,23]. As a result, it can be proposed that the
inhibitory influence of calyculin A arises not from modulation
of CRAC uptake but rather from modulation of membrane
potential resulting in depolarisation. It has been previously
shown in RBL-2H3 cells that activation of the CRAC entry
pathway by antigenic stimulation or inhibition of endosomal
Ca2+-ATPase activity with cyclopiazonic acid is accompanied
by depolarisation [29,31,32]. We have previously reported in
RBL-1 cells that thapsigargin-mediated activation of the CRAC
entry pathway is accompanied by complex transitional changes
in membrane potential between a hyperpolarised potential and
a depolarised potential of approximately 15 mV when
recorded at the single cell level under whole-cell current clamp
[23]. When recorded in cell suspensions using bis-oxonol these
membrane potential changes present as a marked sustained
depolarisation, a finding attributed to the masking of the non-
synchronised transitional changes in potential that occur at the
single cell level [23]. A typical membrane potential response in
RBL-1 cell suspensions in solution containing 5 mM extracel-
lular Ca2+ is shown in Fig. 6A. Application of thapsigargin was
Fig. 8. Membrane depolarisation accompanying activation of the CRAC entry
pathway is reversed by extracellular Gd3+ and Ni2+. (A) Following cel
equilibration with bis-oxonol in basic Na+ solution containing 5 mM Ca2+, 100
nM thapsigargin was added to the cuvette where indicated. At the peak of the
depolarising response 1 AMGdCl3 was added followed by 25 AM2-APB. 200 nM
gramicidin was added to depolarise the cell suspension to 0 mV. (B) Following
cell equilibration with bis-oxonol in basic Na+ solution containing 5 mM Ca2+
100 nM thapsigargin was added to the cuvette where indicated. At the peak of the
depolarising response 5 mM NiCl2 was added followed by 200 nM gramicidin.
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cence attributable to solvent addition followed by a marked
depolarisation to values between 20 mV and potentials
exceeding 0 mV. The onset of the depolarisation displayed a
variable time course with some cells showing a long latent
period prior to depolarisation. Experiments were undertaken to
define the role of activation of CRAC uptake in this marked
depolarisation. Fig. 6B (n =7) shows that inhibition of CRAC
entry by 2-APB addition reversed the depolarisation consistent
with the ability of 2-APB to inhibit the rise in [Ca2+]i mediated
by thapsigargin addition (Fig. 1A).
The thapsigargin-induced depolarisation was also dependent
upon extracellular Ca2+. Thapsigargin addition to cells sus-
pended in nominally Ca2+-free solution was associated with
only a marginal depolarisation that reversed in a time-
dependent fashion (Fig. 7, n =4). However, addition of 5 mM
Ca2+ to the cell suspension is associated with a large
depolarisation sensitive to 2-APB application. Since this
experiment was performed in basic Na+ solution containing 5
mM K+, addition of gramicidin, a monovalent cation channel
forming antibiotic, results in the suspension depolarising to
approximately 0 mV (see Materials and methods). Application
of gramicidin in non-calibrated experiments was used to
indicate the 0-mV value and the relative magnitude of the
changes in potential observed.
The thapsigargin-induced depolarisation was also reversed
by application of 1 AM Gd3+ (Fig. 8A, n =5) or 5 mM Ni2+
(Fig. 8B, n =3), both established inhibitors of CRAC entry in
RBL cells ([22,33] and M.J. Mason unpublished observations).
Further support for the conclusion that the thapsigargin-
mediated depolarisation is dependent upon activation of the
CRAC entry pathway is derived from a comparison of the
latency of the depolarisation following thapsigargin addition
with the biphasic rise in [Ca2+]i observed in fluo-3-loaded cells.
Both the depolarisation latency and the time to the onset of the
secondary rise in [Ca2+]i showed a variability. However, whenFig. 7. Membrane depolarisation accompanying activation of the CRAC entry
pathway is dependent upon extracellular Ca2+. Following cell equilibration
with bis-oxonol in nominally Ca2+-free basic Na+ solution, 100 nM
thapsigargin was added where indicated. Following the small transient
depolarisation, 5 mM Ca2+ was added directly to the cuvette, followed by
addition of 25 AM 2-APB. 200 nM gramicidin was added to depolarise the cell
suspension to 0 mV in accordance with the incorporation of a large monovalent
cation conductance into the plasma membrane (see Materials and methods).
Fig. 9. A comparison of the temporal relationship between the [Ca2+]i and the
membrane potential responses to depletion of intracellular Ca2+ stores induced
by thapsigargin. For comparison purposes, the photomultiplier tube output o
the bis-oxonol record has been scaled. The dashed line indicates the point o
best estimate of the first indication of the onset of depolarisation in the presence
of 5 mM extracellular Ca2+.l
,compared on the same day both relationships showed a similar
temporal relationship. Fig. 9 shows the temporal relationship
between the changes in potential and the changes in [Ca2+]i inf
f
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in which this comparison was performed, an identical
relationship was observed, with the onset of the depolarisation
correlating with the onset of the secondary increase in [Ca2+]i
attributed to activation of the CRAC entry pathway.
3.5. Sensitivity of CRAC uptake-mediated depolarisation to
calyculin A and okadaic acid
The Ca2+ dependence of the depolarisation, its sensitivity to
reversal by 2-APB, Gd3+ and Ni2+ and the close temporal
relationship between the onset of the depolarisation and the
secondary phase of the Ca2+ rise attributable to activation of
CRAC entry all support the contention that activation of the
CRAC entry pathway leading to Ca2+ influx is an absolute
requirement for membrane depolarisation. On the basis of this
conclusion, if calyculin A is an inhibitor of the CRAC entry
pathway one would predict that its addition should reverse the
depolarisation mediated by thapsigargin. Fig. 10A shows aFig. 10. Inhibition by calyculin A of the membrane potential depolarisation
stimulated by activation of the CRAC entry pathway. (A) Following cell
equilibration with bis-oxonol in basic Na+ solution containing 5 mM Ca2+, 100
nM thapsigargin was added to the cuvette where indicated. At the peak of the
depolarising response, 200 nM calyculin A was added followed by 25 AM 2-
APB. 200 nM gramicidin was added to depolarise the cell suspension to 0 mV.
(B) Following cell equilibration with bis-oxonol in basic Na+ solution
containing 5 mM Ca2+ calyculin A was added and the cells incubated for an
additional 7 min prior to the addition of 100 nM thapsigargin. Where indicated,
25 AM 2-APB and 200 nM gramicidin were added.representative result of application of 200 nM calyculin A
during the CRAC uptake pathway-dependent depolarisation.
Addition of calyculin A brings about complete repolarisation of
the cell suspension (n =12). Clearly calyculin A is not altering
the ability of bis-oxonol to report the membrane potential as
addition of gramicidin results in a significant increase in
fluorescence in accordance with depolarisation of the suspen-
sion to 0 mV. Pre-treatment of suspensions with 200 nM
calyculin A also inhibits the thapsigargin-mediated depolarisa-
tion (Fig. 10B, n =3) consistent with the effect of pre-treatment
on the thapsigargin-mediated changes in [Ca2+]i reported in
Fig. 3.
It was necessary to ensure that the ability of calyculin A to
inhibit the CRAC entry pathway arises from its reported
inhibition of type 1/2A phosphatase activity and not as a result
of a direct inhibitory influence at the level of the pathway. To
investigate this, experiments were undertaken with okadaic
acid, a type 1/2A phosphatase inhibitor structurally unrelated to
calyculin A [21] but previously reported by our laboratory to
inhibit store-regulated Ca2+ uptake in rat thymic lymphocytes
[11]. Cell suspensions were incubated with 4 AM okadaic acid
at 37 -C for 15 min prior to addition to the cuvette, equili-
bration with bis-oxonol and the application of thapsigargin.
Addition of thapsigargin under these conditions resulted in a
very small and much delayed, 2-APB-sensitive depolarisation
(Fig. 11B, n =3). In contrast, cells incubated with solvent as a
control showed a robust depolarisation in response to thapsi-
gargin (Fig. 11A, n =3).
4. Discussion
4.1. Sensitivity of CRAC uptake in RBL cells to type 1/2A
serine/threonine phosphatase inhibitors
The present results demonstrate the marked sensitivity of the
CRAC entry pathway in intact RBL-1 cells to inhibition by type
1/2A phosphatase inhibitors. Calyculin A- and okadaic acid-
sensitive phosphatase activity is an absolute requirement for the
activation and sustained Ca2+ transport via the CRAC uptake
pathway. This conclusion is not based solely upon measure-
ments of [Ca2+]i but also unidirectional measurements of Mn
2+
entry. Furthermore, we have exploited the large CRAC entry-
dependent membrane depolarisation as a bioassay for activation
of the CRAC entry pathway. These membrane potential
measurements have also ensured that depolarisation does not
underlie the inhibition detected in the Ca2+ measurements. This
is particularly important given the inward rectification of the
CRAC current in RBL cells. Interestingly, application of
calyculin A is accompanied by a dramatic repolarisation which
would favour Ca2+ entry rather than stimulate the significant
decline in [Ca2+]i that is observed. In this regard, it is interesting
that under control conditions the initial biphasic rise in [Ca2+]i is
followed by a decline in [Ca2+]i to a sustained plateau value. This
fall in [Ca2+]i mirrors the continued depolarisation phase of the
cell suspension evident in Fig. 9, consistent with this depolar-
isation underlying the fall in [Ca2+]i in accordance with the
influences of membrane potential on the CRAC entry pathway.
Fig. 11. Inhibition by okadaic acid of the membrane potential depolarisation
stimulated by activation of the CRAC entry pathway. (A) Control membrane
potential response accompanying activation of the CRAC entry pathway.
Following cell equilibration with bis-oxonol in basic Na+ solution containing 5
mM Ca2+, 100 nM thapsigargin was added to the cuvette where indicated. At
the peak of the depolarising response 25 AM 2-APB was added followed by
200 nM gramicidin to depolarise the suspension to 0 mV. (B) Cells were
incubated for 15 min with 4 AM okadaic acid at 37 -C in basic Na+ solution
containing 1 mM Ca2+. Cells were then centrifuged and resuspended in basic
Na+ solution containing 5 mM Ca2+ and supplemented with 4 AM okadaic acid.
Following equilibration of the cells with bis-oxonol 100 nM thapsigargin, 25
AM 2-APB and 200 nM gramicidin were added where indicated.
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activity for the activation and maintenance of Ca2+ uptake via
the CRAC entry pathway in RBL-1 cells is in agreement with
the previous report of inhibition of the pathway by PKC
stimulation [8]. However, further experiments performed in
RBL-1 cells by members of the same research group revealed
no sensitivity of the CRAC entry pathway to calyculin A [20],
a result difficult to reconcile with the present results. On first
look, it is tempting to ascribe this difference to the use by
these investigators of the whole-cell patch clamp technique.
Dialysis of the cytoplasm with the constituents of the patch
pipette could result in removal of soluble phosphatases and/or
their regulatory subunits or target proteins resulting in a loss
of sensitivity of the signalling process to calyculin A.
However, a similar lack of calyculin A-sensitivity was
reported in a small sample of single-cell measurements of
[Ca2+]i in intact cells. Therefore, dialysis of key regulatory
elements does not appear to account for the difference incalyculin A sensitivity reported by Bakowski and collabora-
tors [20]. An additional point worth considering is that the
experiments of Bakowski et al. [20] and Parekh and Penner
[8] were performed on cells adherent to glass coverslips.
Adherence has been reported to modulate PKC activity [12]
with adherent RBL-2H3 cells displaying constitutively active
PKC activity while cells in suspension did not. Furthermore,
RBL cells grown on coverslips show a very distinct
morphology compared to those grown in suspension, with
adherent cells displaying thin, tail-like projections on the
surface of the coverslip [20] rather than the spherical shape of
RBL cells in suspension. The cytoskeleton has been proposed
to play a critical role in the activation/regulation of SRCU in
the DD1T-2 transformed smooth muscle cell line [16], the
A7r5 smooth muscle cell line [16] and human platelets [17].
Cell adherence does not reconcile the current differences,
however, since we have demonstrated that the modulation of
the Ca2+ response by calyculin A following activation of the
CRAC pathway is indistinguishable in adherent and suspen-
sion cells (Fig. 4).
4.2. Origin of the thapsigargin-induced depolarisation
The origin of the depolarisation observed in response to
activation of the CRAC uptake pathway in RBL-1 cells is
worthy of consideration. Elevations in [Ca2+]i which accom-
pany activation of the pathway may be responsible for
modulation of endogenous channel conductances. Activation
of a Ca2+-activated Na+ channel would be expected to result in
depolarisation. However, such a channel cannot explain the
present results given that an identical calyculin A-sensitive
depolarisation is observed when extracellular Na+ is replaced
with the membrane impermeant monovalent cation NMG
(M.J. Mason, unpublished observations). Activation of a Ca2+-
gated Cl channel could also account for the depolarisation.
However, the existence of such a channel in RBL cells is
unclear. Ca2+-mediated inhibition of the inwardly rectifying
K+ channel has been reported [34,35]. The inward rectifier
represents the dominant conductance setting membrane
potential in RBL cells and inhibition of this channel would
be expected to depolarise RBL cells. The sensitivity of this
channel in RBL cells to inhibition by elevations in [Ca2+]i is
unclear with reports of both Ca2+-dependent inhibition [36]
and reports of no significant modulation by intracellular Ca2+
[37]. While a detailed investigation of the sensitivity of the
inward rectifier has not been undertaken, our preliminary
experiments suggest that Ca2+-dependent inhibition of this
channel does not underlie the depolarisation in the present
experiments.
In the presence of extracellular divalents the CRAC entry
pathway is a low conductance pathway [19] which is highly
Ca2+ selective [33,38]. We have previously proposed that the
depolarisation associated with activation of the CRAC uptake
pathway in RBL-1 cells arises from the interaction between the
very small inward CRAC current and the low membrane
conductance region of the inwardly rectifying K+ channel
current–voltage relationship. We have previously shown that
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to transitionally depolarise RBL cells under whole-cell current
clamp from a potential of approximately 70 mV to values in
excess of 0 mV [23]. While it is unclear what the magnitude of
the CRAC current is under the present experimental conditions,
a current of this magnitude is observed in RBL cells under
whole-cell patch clamp conditions with ionic conditions
designed to isolate Ca2+ currents [8,18,20,22,33,39]. To
increase the magnitude of the inward CRAC current we have
used 5 mM extracellular Ca2+ in the bis-oxonol experiments.
While marked depolarisations can be observed with 1 mM
extracellular Ca2+, 5 mM Ca2+ resulted in consistently large
depolarisations of the cell suspension mediated by the
interaction between the CRAC current and the inwardly
rectifying K+ current.
Knowledge of the exact mechanism underlying the depolar-
isation is not central to the interpretation of the membrane
potential results. The data presented clearly demonstrate that
the depolarisation is dependent upon activation of the CRAC
pathway and as such, membrane potential measurements
provide a useful bioassay for studying activation and regulation
of the CRAC entry pathway. This is important in that such
measurements are not dependent upon invasive techniques
such as whole-cell patch clamp or loading cells with
fluorescent Ca2+ indicators which can significantly alter the
true Ca2+ dynamics of the cell as a result of alterations in
intracellular Ca2+ buffering.
4.3. Site of action of the phosphorylation/dephosphorylation
cycle
While it is well established that serine/threonine phosphor-
ylation/dephosphorylation reactions modulate SRCU, [3–
10,13–16] the site or sites of phosphorylation are unclear.
Given the reported inhibitory influence of protein kinase C
activity on the CRAC uptake pathway [8] modulation of
phosphatase activity becomes a critical regulatory process
particularly during activation of the CRAC pathway mediated
via physiological agonists linked to activation of phospholi-
pase C. Under these conditions, the generation of inositol
1,4,5 trisphosphate is accompanied by the production of
diacylglycerol and an increase in PKC activity. CRAC
activation can only occur if phosphatase activity can
effectively counter the PKC influences on the phosphorylation
state of the target proteins, an observation previously appreci-
ated in the light of the inhibitory influence of PKC stimulation
[8].
The finding that phosphatase activity is absolutely required
for CRAC entry in our hands is not confined to the RBL-1
clone. We have also found that the depolarisation induced by
thapsigargin is inhibited by calyculin A and okadaic acid in
RBL-2H3 cell suspensions (M.J. Mason unpublished observa-
tions). Additionally, incubation with nor-okadaone, a structur-
ally related okadaic acid analogue lacking inhibitory
phosphatase activity had no influence on the thapsigargin-
mediated depolarisation, consistent with phosphatase inhibition
underlying repolarisation of the cell suspension (M.J. Mason,unpublished observations). Further experiments in RBL-2H3
cells have demonstrated that thapsigargin-induced Mn2+ entry
measured as quench of intracellular indo-1 fluorescence at its
isosbestic wavelength was also completely inhibited by
calyculin A (M.J. Mason, unpublished observations). Taken
in concert, these data indicate that the CRAC uptake pathway
in RBL cells, independent of their clonal origin, displays a
requirement for type 1/2A phosphatase activity, a finding
consistent with previous observations of SRCU in a variety of
cell types [4,11,13–17].
While the present experiments were undertaken at room
temperature in an attempt to mimic the experimental conditions
of Bakowski et al. [20], preliminary experiments were
undertaken at 37 -C. We have observed identical calyculin A
sensitivity of the membrane potential changes induced by
thapsigargin at 37 -C. Additionally, thapsigargin-stimulated
Mn2+ entry in RBL-2H3 cells is also inhibited at this
temperature. These results are consistent with a requirement
for phosphatase activity across a broad range of temperatures.
The present results demonstrate that inhibition of phos-
phatase activity effectively inhibits CRAC entry both when
applied before depletion of Ca2+ stores or after full activation
of the pathway, indicating that prior activation of the pathway
is not required for the inhibitory influence of calyculin A to
be manifested. Modulation of phosphatase and/or kinase
activity by the Ca2+ status of the intracellular stores provides
a mechanism that could explain the link between intracellular
Ca2+ stores and the regulation of the CRAC uptake pathway.
In this model net dephosphorylation of target protein(s) would
lead to activation of the CRAC entry pathway. Net
dephosphorylation could occur directly at the level of the
CRAC entry pathway or more indirectly at the level of
control of more complex signalling cascades proposed to
underlie activation following Ca2+ store depletion such as
diffusible messengers [40–45], conformational coupling
[17,46] or secretion-like coupling [16,47,48]. Type 1/2A
serine/threonine phosphatase activity is regulated by numer-
ous regulatory subunits which interact with its catalytic
subunit [49,50]. Phosphatase activity may be regulated by
modulation of subunit availability controlled by the Ca2+
content of intracellular store. More work is required to
understand the regulation of type1/2A phosphatase activity
during Ca2+ signalling and to localise the site(s) at which
phosphorylation regulates the CRAC entry pathway in RBL
cells. However, it is clear from the present experiments that
phosphatase activity plays a critical role in its activation and/
or regulation.
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